This article first appeared on GuruFocus.
-
Q3 2025 Revenue: $1.5 million, down from $2.1 million in Q3 2024.
-
Year-to-Date Revenue: Slightly under $5 million.
-
License Fee Revenue: $918,000 in Q3 2025, down from $1.4 million in Q3 2024.
-
Service Revenue: $268,000 in Q3 2025, slightly up from $267,000 in Q3 2024.
-
Hardware Sales: $364,000 in Q3 2025, down from $436,000 in Q3 2024.
-
Gross Margin: 77% in Q3 2025, compared to 78% in Q3 2024.
-
Operating Expenses: Decreased 8% to $2.1 million in Q3 2025 from $2.3 million in Q3 2024.
-
Net Loss: $965,000 or $0.15 per share in Q3 2025, compared to $739,000 or $0.39 per share in Q3 2024.
-
Cash Position: $2 million as of September 30, 2025, up from $438,000 at year-end 2024.
-
Recent Funding: Raised approximately $3 million net of fees through a warrant exercise transaction.
Release Date: November 14, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
-
BIO-key International Inc (NASDAQ:BKYI) reported a strong gross margin of 77% in Q3 2025, maintaining a high level of profitability.
-
The company has successfully reduced operating expenses by over 10% in the first nine months of 2025, demonstrating effective cost management.
-
BIO-key International Inc (NASDAQ:BKYI) has secured a significant $3 million in funding through a warrant exercise, enhancing its cash liquidity and financial position.
-
The company is experiencing high renewal rates in excess of 90%, indicating strong customer retention and satisfaction.
-
BIO-key International Inc (NASDAQ:BKYI) is expanding its market reach with a growing pipeline of opportunities in the defense sector, banking, and other industries, supported by its unique biometric solutions.
-
Q3 2025 revenue decreased by approximately $595,000 year-over-year, primarily due to the absence of large orders from the previous year.
-
The company experienced a net loss of $965,000 in Q3 2025, compared to a net loss of $739,000 in Q3 2024, reflecting challenges in achieving profitability.
-
Revenue for the first nine months of 2025 was slightly under $5 million, showing a decrease compared to the previous year, attributed to timing issues with customer orders.
-
BIO-key International Inc (NASDAQ:BKYI) faces variability in quarterly revenues due to the timing of renewals and new deployments, impacting financial predictability.
-
The company is still in the process of finalizing new marketing messaging and a major website overhaul, indicating ongoing efforts to improve market positioning and outreach.